APA

Lichtenegger F. S., Kondla I., Krempasky M., Weber A. L., Herold T., Krupka C., Spiekermann K., Schneider S., Büchner T., Berdel W. E., Wörmann B. J., Hiddemann W. & Subklewe M. (20160229). RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML. : Cancer immunology, immunotherapy : CII.

Chicago

Lichtenegger Felix S, Kondla Isabell, Krempasky Michael, Weber Anna L, Herold Tobias, Krupka Christina, Spiekermann Karsten, Schneider Stephanie, Büchner Thomas, Berdel Wolfgang E, Wörmann Bernhard J, Hiddemann Wolfgang and Subklewe Marion. 20160229. RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML. : Cancer immunology, immunotherapy : CII.

Harvard

Lichtenegger F. S., Kondla I., Krempasky M., Weber A. L., Herold T., Krupka C., Spiekermann K., Schneider S., Büchner T., Berdel W. E., Wörmann B. J., Hiddemann W. and Subklewe M. (20160229). RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML. : Cancer immunology, immunotherapy : CII.

MLA

Lichtenegger Felix S, Kondla Isabell, Krempasky Michael, Weber Anna L, Herold Tobias, Krupka Christina, Spiekermann Karsten, Schneider Stephanie, Büchner Thomas, Berdel Wolfgang E, Wörmann Bernhard J, Hiddemann Wolfgang and Subklewe Marion. RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML. : Cancer immunology, immunotherapy : CII. 20160229.